We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QELL
176
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
| $7.46M | 0.14% |
+750,001
| New | +$7.46M |
|
|
AUS
177
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $7.44M | 0.14% |
+750,000
| New | +$7.44M |
|
178
Dave Inc
DAVE
$4.74B
| $7.42M | 0.14% |
+23,438
| New | +$7.4M |
|
179
NetEase
NTES
$85.3B
| $7.31M | 0.14% |
63,452
-11,707
| -16% | -$1.29M |
|
180
Qorvo
QRVO
$7.99B
| $7.17M | 0.13% |
36,669
-218,611
| -86% | -$40.3M |
|
181
Bausch Health
BHC
$2.58B
| $7.13M | 0.13% |
+243,214
| New | +$7.37M |
|
182
Hayward Holdings
HAYW
$3.21B
| $7.1M | 0.13% |
272,746
+7,489
| +3% | +$163K |
|
183
Seer Inc
SEER
$122M
| $7.03M | 0.13% |
214,461
+1,310
| +0.6% | +$51.7K |
|
184
Align Technology
ALGN
$12.1B
| $6.99M | 0.13% |
11,444
+2,002
| +21% | +$1.18M |
|
185
Perrigo
PRGO
$1.4B
| $6.95M | 0.13% |
+151,639
| New | +$6.72M |
|
186
Lumentum
LITE
$55.5B
| $6.92M | 0.13% |
+84,338
| New | +$7.09M |
|
187
Eledon Pharmaceuticals
ELDN
$261M
| $6.78M | 0.13% |
857,445
-33,610
| -4% | -$317K |
|
|
LITS
188
Lite Strategy Inc
LITS
$32.8M
| $6.73M | 0.13% |
118,031
+86,164
| +270% | +$5.53M |
|
|
AERI
189
DELISTED
Aerie Pharmaceuticals
AERI
| $6.71M | 0.13% |
419,140
-1,737,899
| -81% | -$29.8M |
|
190
Estee Lauder
EL
$30.4B
| $6.6M | 0.12% |
20,760
+3,081
| +17% | +$934K |
|
191
MacroGenics
MGNX
$235M
| $6.6M | 0.12% |
+245,596
| New | +$7.19M |
|
192
Praxis Precision Medicines
PRAX
$8.58B
| $6.52M | 0.12% |
23,763
+6,985
| +42% | +$2.5M |
|
193
Forte Biosciences
FBRX
$1.57B
| $6.51M | 0.12% |
7,747
+134
| +2% | +$121K |
|
194
Universal Health Services
UHS
$10.2B
| $6.5M | 0.12% |
+44,370
| New | +$6.71M |
|
|
SKINW
195
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
| $6.4M | 0.12% |
+1,000,000
| New | +$4.29M |
|
196
Immatics
IMTX
$1.18B
| $6.37M | 0.12% |
548,927
-50,726
| -8% | -$595K |
|
|
SWBK
197
DELISTED
Switchback II Corporation
SWBK
| $6.37M | 0.12% |
+643,947
| New | +$6.39M |
|
198
HP
HPQ
$24.9B
| $6.14M | 0.11% |
203,524
-275,943
| -58% | -$8.82M |
|
|
HCIC
199
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
| $6.07M | 0.11% |
600,002
+471,267
| +366% | +$4.68M |
|
|
KNTE
200
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $6.06M | 0.11% |
260,276
-25,853
| -9% | -$658K |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.